Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021
EDEN PRAIRIE, Minn. , Feb. 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter 2020 financial results will be released on Tuesday, March 2, 2021 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
EDEN PRAIRIE, Minn. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application to increase monitoring capabilities with its Aquadex
View HTML
Toggle Summary CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using
View HTML
Toggle Summary CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Real-World Experience
View HTML
Toggle Summary CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
EDEN PRAIRIE, Minn. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo , Jr.
View HTML
Toggle Summary CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
EDEN PRAIRIE, Minn. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its
View HTML
Toggle Summary CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF
EDEN PRAIRIE, Minn. , Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced a meta-analysis published in Heart Failure Review s concludes that ultrafiltration (UF) increases
View HTML
Toggle Summary CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.
EDEN PRAIRIE, Minn. , Dec. 04, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that Ladenburg Thalman & Co. will host a conference call and webcast at 1:00p.m.
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Nov. 23, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective November 16, 2020 , the independent directors approved three equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to three individuals
View HTML
Toggle Summary CHF Solutions, Inc. Announces 52 Percent Increase in Revenue for Third Quarter 2020 and Provides Company Update
EDEN PRAIRIE, Minn. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the third quarter ended September 30, 2020 . Recent Highlights Revenue for the third quarter of 2020 was $1.9 million , an increase of 52% compared to the prior year period
View HTML